Mirella Ezban

Senior Vice President Rare Disorders
NovoNordisk A/S

Presentation(s):

• OC 17.2 - The measurement of a next-generation FVIII Mimetic, Mim8, using tissue factor triggered calibrated automated thrombography

  Sunday, July 10, 2022
  11:00 AM – 11:15 AM

• PB0217 - Impacts of Mim8 on routine coagulation assays, on intrinsic pathway coagulation factor assays and on thrombophilia coagulation tests

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM

• PB0218 - Adaptative methods using one-stage and chromogenic substrate assays for the quantitative measurement of Mim8 in human plasma

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM

• PB0223 - Mim8 does not affect FVIII function in hemophilia A

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM

• PB0226 - Assay of the factor VIIIa mimetic, Mim8, using one-stage clotting assay requires a product-specific reference material

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM

• PB1059 - Next-generation FVIII mimetic, Mim8, does not interfere with non-factor VIII haemostasis assays.

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM